Agoraphobia Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Funding
• Clinical Trials
• Forums

A 14 Week, Randomized, Placebo-Controlled Cross-Over Study of Methylphenidate Hydrochloride Controlled Release Capsules in Adult ADHD With and Without Anxiety Disorder Comorbidity
Conditions:   Attention Deficit Hyperactivity Disorder;   Generalized Anxiety Disorder;   Social Anxiety Disorder;   Panic Disorder;   Agoraphobia Interventions:   Drug: Methylphenidate Hydrochloride Controlled-Release Capsules;   Drug: Placebo Capsule Sponsors:   McMaster University;   Purdue Pharma LP Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 24, 2018 Category: Research Source Type: clinical trials